The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)

被引：7
|
作者：
Al-kuraishy, Hayder M. [1 ]
Al-Gareeb, Ali I. [1 ]
Saad, Hebatallah M. [2 ]
Batiha, Gaber El-Saber [3 ]
机构：
[1] Al Mustansiriyah Univ, Coll Med, Med Fac, Dept Pharmacol Toxicol & Med, POB 14132, Baghdad, Iraq
[2] Matrouh Univ, Fac Vet Med, Dept Pathol, Marsa Matruh 51744, Egypt
[3] Damanhour Univ, Fac Vet Med, Dept Pharmacol & Therapeut, Damanhour 22511, Egypt
来源：
INFLAMMOPHARMACOLOGY | 2023年 / 31卷 / 04期
关键词：
Fibroblast growth factor 21; T2DM; Metformin; DIFFERENTIATION FACTOR 15; GLUCAGON-LIKE PEPTIDE-1; FGF21; ANALOG; LIPID-METABOLISM; FATTY LIVER; INSULIN; GLUCOSE; EXPRESSION; OBESITY; ACID;
D O I：
10.1007/s10787-023-01255-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Fibroblast growth factor 21 (FGF21) is a peptide hormone mainly synthesized and released from the liver. FGF21 acts on FGF21 receptors (FGFRs) and & beta;-Klotho, which is a transmembrane co-receptor. In type 2 diabetes mellitus (T2DM), inflammatory disorders stimulate the release of FGF21 to overcome insulin resistance (IR). FGF21 improves insulin sensitivity and glucose homeostasis. Metformin which is used in the management of T2DM may increase FGF21 expression. Accordingly, the objective of this review was to clarify the metformin effect on FGF21 in T2DM. FGF21 level and expression of FGF2Rs are dysregulated in T2DM due to the development of FGF21 resistance. Metformin stimulates the hepatic expression of FGF21/FGF2Rs by different signaling pathways. Besides, metformin improves the expression of & beta;-Klotho which improves FGF21 sensitivity. In conclusion, metformin advances FGF21 signaling and decreases FGF21 resistance in T2DM, and this might be an innovative mechanism for metformin in the enhancement of glucose homeostasis and metabolic disorders in T2DM patients.
引用
收藏
页码：1751 / 1760
页数：10
相关论文
共 50 条
  • [31] The predicted mechanisms and evidence of probiotics on type 2 diabetes mellitus (T2DM)
    Bajinka, Ousman
    Sylvain Dovi, Kodzovi
    Simbilyabo, Lucette
    Conteh, Ishmail
    Tan, Yurong
    [J]. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2024, 130 (04) : 475 - 490
  • [32] Type 2 diabetes mellitus (T2DM) and cognition - A cross sectional study
    Moran, C.
    Phan, T. G.
    Beare, R.
    Chen, J.
    Blizzard, L.
    Venn, A.
    Greenaway, T.
    Munch, G.
    Forbes, J.
    Pearson, S.
    Srikanth, V
    [J]. AUSTRALASIAN JOURNAL ON AGEING, 2012, 31 : 21 - 21
  • [33] In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM)
    Sliwinska, Agnieszka
    Blasiak, Janusz
    Kasznicki, Jacek
    Drzewoski, Jozef
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2008, 173 (03) : 159 - 165
  • [34] HDL EFFLUX CAPACITY, AND PARTICLE REMODELLING IN PATIENTS WITH TYPE 1 DIABETES MELLITUS (T1DM) AND TYPE 2 DIABETES MELLITUS (T2DM)
    Byrne, R.
    Curley, S.
    Ahmed, K.
    Ahmed, M.
    Gibney, J.
    Mcgillicuddy, F.
    [J]. ATHEROSCLEROSIS, 2020, 315 : E65 - E66
  • [35] Effect of baseline glycemic status on the efficacy of oral agents in type 2 diabetes mellitus (T2DM)
    Inzucchi, SE
    Dodis, R
    Viscoli, CM
    Holmboe, ES
    Bloomgarden, ZT
    [J]. DIABETES, 2004, 53 : A476 - A476
  • [36] The effect of metformin on autophagy by LC3 expression in Type 2 Diabetes Mellitus (T2DM) human skeletal muscle cell culture
    Prajitno, Jongky Hendro
    Pranoto, Agung
    Adiwinoto, Robert Dwitama
    Soelistijo, Soebagijo Adi
    [J]. BALI MEDICAL JOURNAL, 2022, 11 (01) : 349 - 355
  • [37] Metformin treatment in a boy with hepatocyte nuclear factor-1A (HNF-1A) mutation and criteria of type 2 diabetes mellitus (T2DM)
    Decker, Ralph
    Jacobeit, Jens
    [J]. HORMONE RESEARCH, 2006, 65 : 54 - 55
  • [38] The serum fibroblast growth factor 21 is correlated with retinopathy in patients with type 2 diabetes mellitus
    Heidari, Zahra
    Hasanpour, Mahdieh
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (06)
  • [39] Benefits beyond glycemia of adding rosiglitazone rather than glyburide to metformin monotherapy in type 2 diabetes mellitus (T2DM)
    Rood, JA
    Ryan, CM
    Cobitz, AR
    Waterhouse, BR
    Strachan, MWJ
    [J]. DIABETES, 2004, 53 : A480 - A480
  • [40] Life Expectancy of Individuals with Type 2 Diabetes Mellitus (T2DM) in the United States
    Kianmehr, Hamed
    Yang, Shuang
    Fonseca, Vivian
    Shi, Lizheng
    Brown, Joshua D.
    Guo, Yi
    Shao, Hui
    [J]. DIABETES, 2020, 69
12345